1William Harvey Research Institute, St Bartholomew's Hospital Medical College, London, U.K.
Developing specific inhibitors for 5- and 12-lipoxygenase will improve understanding of their roles in skin. Clinical trials of lipocortins will further elucidate steroid mechanisms in skin diseases.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: